Literature DB >> 16714356

Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats.

Christine L Oltman1, Laura L Richou, Eric P Davidson, Lawrence J Coppey, Donald D Lund, Mark A Yorek.   

Abstract

We investigated the progression of vascular dysfunction associated with the metabolic syndrome with and without hyperglycemia in lean, Zucker obese, and Zucker diabetic fatty (ZDF) rats. Responses of aorta and small coronary and mesenteric arteries were measured to endothelium-dependent and -independent vasodilators. Indices of oxidative stress were increased in serum from ZDF rats throughout the study, whereas values were increased in Zucker obese rats later in the study [thiobarbituric acid reactive substances: 0.45 +/- 0.02, 0.59 +/- 0.03 (P < 0.05), and 0.58 +/- 0.03 (P < 0.05) mug/ml in serum from 28- to 40-wk-old lean, Zucker obese, and ZDF rats, respectively]. Acetylcholine (ACh)-induced relaxation was not altered in vessels from lean animals from 8-40 wk. ACh-induced relaxation was nearly abolished in coronary arteries from 28- to 36-wk-old Zucker obese rats and by 16-36 wk in ZDF rats and was attenuated in aorta and mesenteric vessels from ZDF rats [%relaxation to 10 muM ACh: 72.2 +/- 7.1, 17.9 +/- 5.9 (P < 0.05), and 23.0 +/- 4.5 (P < 0.05) in coronary vessels; and 67.9 +/- 9.2, 50.1 +/- 5.5, and 42.3 +/- 4.7 (P < 0.05) in mesenteric vessels from 28- to 40-wk-old lean, Zucker obese, and ZDF rats, respectively]. The attenuated ACh-induced relaxation was improved when vessels were incubated with tiron, suggesting superoxide as a mechanism of endothelial dysfunction. Sodium nitroprusside-induced relaxation was not altered in aorta or coronary arteries and was potentiated in mesenteric arteries from Zucker obese rats. Our data suggest that diabetes enhances the progression of vascular dysfunction. Increases in indices of oxidative stress precede the development of dysfunction and may serve as a marker of endothelial damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714356     DOI: 10.1152/ajpheart.01297.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  54 in total

1.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

2.  Redundancy control in pathway databases (ReCiPa): an application for improving gene-set enrichment analysis in Omics studies and "Big data" biology.

Authors:  Juan C Vivar; Priscilla Pemu; Ruth McPherson; Sujoy Ghosh
Journal:  OMICS       Date:  2013-06-11

Review 3.  Modulation of endothelial cell phenotype by physical activity: impact on obesity-related endothelial dysfunction.

Authors:  Shawn B Bender; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

Review 4.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

5.  Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction.

Authors:  Huijuan Dou; Attila Feher; Alec C Davila; Maritza J Romero; Vijay S Patel; Vinayak M Kamath; Monika Beck Gooz; R Daniel Rudic; Rudolf Lucas; David J Fulton; Neal L Weintraub; Zsolt Bagi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

Review 6.  Obesity and coronary microvascular disease - implications for adipose tissue-mediated remote inflammatory response.

Authors:  Zsolt Bagi; Zuzana Broskova; Attila Feher
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

Review 7.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

8.  Adipose tissue and vascular phenotypic modulation by voluntary physical activity and dietary restriction in obese insulin-resistant OLETF rats.

Authors:  Jacqueline M Crissey; Nathan T Jenkins; Kasey A Lansford; Pamela K Thorne; David S Bayless; Victoria J Vieira-Potter; R Scott Rector; John P Thyfault; M Harold Laughlin; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

9.  Impaired coronary function in Wistar Ottawa Karlsburg W rats-a new model of the metabolic syndrome.

Authors:  Olaf Grisk; Tillmann Frauendorf; Torsten Schlüter; Ingrid Klöting; Beate Kuttler; Alexander Krebs; Jan Lüdemann; Rainer Rettig
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

10.  NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats.

Authors:  E Brøndum; H Kold-Petersen; U Simonsen; Christian Aalkjaer
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.